Tags: Featured, Honors
E. Krop led a study showing that the anti-body drug ado-trastuzumab emtansine
significantly prolonged progression-free survival in patients with progressive
HER2-positive advanced breast cancer.
Eric P. Winer co-chaired an expert panel that developed a clinical practice
guideline on disease management for patients with advanced HER2-positive breast
cancer and brain metastases.
Paul L. Nguyen led a study showing prostate cancer patients with health
insurance are less likely to have metastatic disease or die from the
cancer than those without health insurance.
Robert Haddad commented on JPMorgan Chase CEO Jamie Dimon being diagnosed with throat cancer.
Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215 | Call us toll-free: